Does smoking cessation reduce other substance use, psychiatric symptoms, and pain symptoms? Results from an emulated hypothetical randomized trial of US veterans.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Smoking Cessation*/psychology ; Smoking Cessation*/methods ; Veterans*/psychology ; Pain* ; Substance-Related Disorders*/epidemiology ; Substance-Related Disorders*/psychology; Humans ; Male ; Female ; Middle Aged ; United States/epidemiology ; Adult ; Aged ; Depression/epidemiology ; Anxiety/epidemiology ; Longitudinal Studies ; Cigarette Smoking/epidemiology

Background: Quitting smoking may lead to improvement in substance use, psychiatric symptoms, and pain, especially among high-risk populations who are more likely to experience comorbid conditions. However, causal inferences regarding smoking cessation and its subsequent benefits have been limited.
Methods: We emulated a hypothetical open-label randomized control trial of smoking cessation using longitudinal observational data of HIV-positive and HIV-negative US veterans from 2003-2015 in the Veterans Aging Cohort Study. We followed individuals from the first time they self-reported current cigarette smoking (baseline). We categorized participants as quitters or non-quitters at the first follow-up visit (approximately 1 year after baseline). Using inverse probability weighting to adjust for confounding and selection bias, we estimated odds ratios for improvement of co-occurring conditions (unhealthy alcohol use, cannabis use, illicit opioid use, cocaine use, depressive symptoms, anxiety symptoms, and pain symptoms) at second follow-up (approximately 2 years after baseline) for those who quit smoking compared to those who did not, among individuals who had the condition at baseline.
Results: Of 4,165 eligible individuals (i.e., current smokers at baseline), 419 reported no current smoking and 2,330 reported current smoking at the first follow-up. Adjusted odds ratios (95% confidence intervals) for associations between quitting smoking and improvement of each condition at second follow-up were: 2.10 (1.01, 4.35) for unhealthy alcohol use, 1.75 (1.00, 3.06) for cannabis use, 1.10 (0.58, 2.08) for illicit opioid use, and 2.25 (1.20, 4.24) for cocaine use, 0.78 (0.44, 1.38) for depressive symptoms, 0.93 (0.58, 1.49) for anxiety symptoms, and 1.31 (0.84, 2.06) for pain symptoms.
Conclusions: While a causal interpretation of our findings may not be warranted, we found evidence for decreased substance use among veterans who quit cigarette smoking but none for the resolution of psychiatric conditions or pain symptoms. Findings suggest the need for additional resources combined with smoking cessation to reduce psychiatric and pain symptoms for high-risk populations.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2024 Ban et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)

Med Care. 1996 Mar;34(3):220-33. (PMID: 8628042)
JAMA Netw Open. 2020 Mar 2;3(3):e200895. (PMID: 32163167)
Pain. 2020 Aug;161(8):1688-1693. (PMID: 32701828)
Tob Control. 2014 Nov;23(e2):e147-53. (PMID: 24727731)
Addiction. 2016 Oct;111(10):1786-94. (PMID: 27061707)
J Anxiety Disord. 2006;20(5):597-613. (PMID: 16202562)
Clin Infect Dis. 2011 Dec;53(11):1120-6. (PMID: 21998278)
Psychol Bull. 2011 Nov;137(6):1065-93. (PMID: 21967450)
Expert Rev Neurother. 2013 Dec;13(12):1407-14. (PMID: 24236905)
Curr Med Res Opin. 2022 Aug;38(8):1443-1450. (PMID: 35757905)
Addict Behav. 2019 Dec;99:106112. (PMID: 31476691)
Alcohol Clin Exp Res. 2005 Nov;29(11):2001-7. (PMID: 16340457)
Pain Med. 2021 Aug 6;22(8):1793-1803. (PMID: 33502511)
Drugs. 2006;66(6):769-89. (PMID: 16706551)
J Gen Intern Med. 2001 Sep;16(9):606-13. (PMID: 11556941)
Nicotine Tob Res. 2009 Dec;11(12):1407-14. (PMID: 19828432)
J Clin Epidemiol. 2001 Dec;54 Suppl 1:S3-8. (PMID: 11750202)
Prev Med. 2018 Jun;111:231-234. (PMID: 29550303)
Am J Addict. 2005 Mar-Apr;14(2):106-23. (PMID: 16019961)
Addiction. 2012 Jul;107(7):1221-33. (PMID: 22300456)
Nicotine Tob Res. 2008 Dec;10(12):1691-715. (PMID: 19023823)
Nicotine Tob Res. 2011 Dec;13(12):1233-9. (PMID: 21911825)
J Clin Psychiatry. 2018 May/Jun;79(3):. (PMID: 29894597)
Medicine (Baltimore). 2021 Apr 23;100(16):e25428. (PMID: 33879673)
J Acquir Immune Defic Syndr. 2020 May 1;84(1):26-36. (PMID: 32267658)
J Consult Clin Psychol. 2004 Dec;72(6):1144-56. (PMID: 15612860)
Cochrane Database Syst Rev. 2021 Mar 9;3:CD013522. (PMID: 33687070)
Drug Alcohol Depend. 2014 Jan 1;134:391-395. (PMID: 24128381)
Am J Epidemiol. 2016 Apr 15;183(8):758-64. (PMID: 26994063)
J Clin Epidemiol. 2001 Dec;54 Suppl 1:S77-90. (PMID: 11750213)
Addict Behav. 2015 Oct;49:26-32. (PMID: 26036666)
Ann Intern Med. 2017 Aug 15;167(4):268-274. (PMID: 28693043)
JAMA. 1990 Sep 26;264(12):1541-5. (PMID: 2395193)
J Clin Epidemiol. 2016 Nov;79:70-75. (PMID: 27237061)
J Environ Public Health. 2012;2012:918368. (PMID: 22649464)
Addict Behav. 2017 Feb;65:161-170. (PMID: 27816663)
Psychol Med. 2014 Sep;44(12):2523-35. (PMID: 25055171)
Am J Psychiatry. 2000 Feb;157(2):248-54. (PMID: 10671395)
J Gen Intern Med. 2002 Jul;17(7):512-20. (PMID: 12133141)
Alcohol Res Health. 2006;29(3):162-71. (PMID: 17373404)

Date Created: 20240703 Date Completed: 20240703 Latest Revision: 20240705

20240705

PMC11221691

10.1371/journal.pone.0298576

38959263